Clinical Study Evaluating the Efficacy and Safety of Synbiotic as an Adjuvant Therapy in the Treatment of Parkinson's Disease

Trial ID: NCT05576818

Interventional - Phase 3 - Recruiting

This study aims to investigate the possible efficacy and safety of synbiotic preparation of Lactobacillus acidophilus probiotic with prebiotic fibers as an adjuvant therapy in the treatment of Parkinson's disease

Conditions

• Parkinson's Disease

Interventions

• Lactobacillus acidophilus 10 billion colony forming unit (CFU) and prebiotic fibers

Eligibility

Inclusion criteria

• Age between 45 and 65 years old
• Both sexes
• Patients with Parkinson's disease on dopamine replacement therapy
• Modified Hoehn and Yahr stage, MHY 1-4

Exclusion criteria

• Patients who are currently using or used antibiotics therapy in the preceding month
• Patients who are currently using or used other probiotic products in the preceding two weeks
• Patients scheduled to undergo GIT surgery or those underwent GIT surgery
• Patients with Known allergy to probiotics
• Patients receiving artificial enteral or intravenous nutrition
• Patients with depression and/or psychosis
• Patients taking antioxidant and/or anti-inflammatory medications
• Patients with Hyperthyroidism
• Patients with inflammatory condition and/or condition involving oxidative stress
• Smokers
• Modified Hoehn \& Yahr stage MHY 5

Sponsor

Tanta University

Source: ClinicalTrials.gov

Search more clinical trials on myTomorrows